Source: THE HINDU

Exelan Pharmaceuticals: Cipla to acquire two U.S. pharma firms

This acquisition also provides Cipla with about 40 approved Abbreviated New Drug Applications (ANDAs), 32 marketed products, and 30 pipeline products.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
$1.2M
Est. Employees
10
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more